The recent surge in investments into niche pharmaceutical companies, particularly those focusing on experimental therapies and difficult drug development programs, has fueled what some are calling "High Roller Pharma." https://tayagkrq036317.blogerus.com/62031537/high-investor-pharma-the-hazardous-wager